Back to Results
First PageMeta Content
Pharmacology / Benzimidazoles / Pyridines / Sulfoxides / Gastroenterology / Omeprazole / Esomeprazole / Helicobacter pylori / Rabeprazole / Medicine / Chemistry / Proton pump inhibitors


News Release Takeda Pharmaceutical Company Limited AstraZeneca K.K. Mitsubishi Tanabe Pharma Corporation Eisai Co., Ltd. Companies Submit Joint Application Seeking Approval for Additional Indication for
Add to Reading List

Document Date: 2012-08-31 03:11:29


Open Document

File Size: 58,75 KB

Share Result on Facebook

City

Tokyo / Osaka / /

Company

Eisai Co. Ltd. Companies / Taisho Pharmaceutical Co. Ltd. / Eisai Co. Ltd. / Kyowa Hakko Kirin Co. Ltd. / Takeda Pharmaceutical Company Limited / Shionogi & Co. Ltd. / ABBOTT JAPAN Co. LTD. / Mitsubishi Tanabe Pharma Corporation / Astellas Pharma Inc. / AstraZeneca K.K. Mitsubishi Tanabe Pharma Corporation / News Release Takeda Pharmaceutical Company Limited / /

Country

Japan / /

MedicalCondition

gastric and duodenal ulcers / gastric cancer / chronic active gastritis / H. pylori infection / H. pylori gastritis / gastric MALT lymphoma / gastritis / diseases / inflammatory cells / idiopathic thrombocytopenic purpura / histological gastric mucosal injury / /

MedicalTreatment

Concomitant Therapy / /

Organization

Research and Development Division / Japan Gastroenterological Endoscopy Society / Japanese Society for Helicobacter Research / Japanese Society of Gastroenterology / Evaluation and Licensing Division / Ministry of Health / /

Person

Michihiro Tsuchiya / Labour / Paul Hudson / /

Position

President / President and CEO / Minister of Health / /

Product

Flagyl / rabeprazole sodium / esomeprazole magnesium / Nexium / OD Tablets / Metronidazole / Amoxicillin / lansoprazole / Clarithromycin / omeprazole / /

SocialTag